We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Coronavirus Vaccine Hopes Buoy Market: 4 Stocks to Tap the Rally
Read MoreHide Full Article
The Dow Jones Industrial Average (DJIA) has risen for four successive days, marking the longest winning streak in more than 30 days. This indicates positive investor sentiments, aided primarily by the promising progress in coronavirus vaccine study. Increased U.S. industrial production also added to the optimism.
Promising Vaccine Study
Moderna (MRNA - Free Report) has inched closer to a coronavirus vaccine, setting the stage for phase 3 trial by July-end, as suggested by a new study. The new details of the phase 1 study of the company’s experimental coronavirus vaccine showed that the vaccine induced desired neutralizing antibodies in 100% of the participants who were evaluated.
Notably, no serious side effects were reported by the participants through the study period, signifying that the vaccine was well tolerated and safe. Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, appreciated the study and added that the data from the phase 1 trial has established the fact that the candidate is well capable of inducing sufficient neutralizing antibodies.
It is widely expected that the results from the large study will come out by 2020-end.
Sign of Economic Recovery
Industrial production in the United States increased 5.4% in June following the improvement of 1.4% in May, according to the Federal Reserve statistical release. Thus, U.S. manufacturing has increased for two months in a row after declining 12.7% in April. Notably, the rise in industrial production was higher than the expectations of most economists.
Importantly, social-distancing measures were eased and people returned to work as factories in the United States reopened in May and June. This has helped industrial production recover from its record decline in April.
Stocks in the Spotlight
With the string of positive developments aiding the stock market rally, it will be wise for the investors to invest in growth stocks. Growth stocks usually grow at a rate higher than the market’s average. Hence, we have shortlisted four stocks that flaunt a Zacks Rank #1 (Strong Buy) and possess a Growth Score of A. You can see the complete list of today’s Zacks #1 Rank stocks here.
BJ’s Wholesale Club Holdings, Inc. (BJ - Free Report) : BJ’s Wholesale is an operator of membership warehouse clubs, primarily in the U.S. East Coast. Notably, this Westborough, MA-headquartered company’s expected EPS growth rate for the next five years is 13.5%, which compares favorably with the industry's 12.3%.
Asbury Automotive Group, Inc. (ABG - Free Report) is a leading automotive retailer in the domestic market. The stock is likely to see earnings growth of 2.9% and 22.7% in 2020 and 2021, respectively. The company, headquartered in Duluth, GA, has also beat the Zacks Consensus Estimate in three of the past four reported quarters.
DCP Midstream, LP has operating interests in midstream energy infrastructures spreading across the United States. The partnership has witnessed no revisions in the Zacks Consensus Estimate for 2020 bottom line in the past 30 days. For 2021, the partnership has seen upward revisions for the consensus estimate of earnings over the same period.
Based in Covington, LA, Pool Corporation (POOL - Free Report) is among the largest distributors of swimming pool supplies in the world. In the past 60 days, the company has seen upward revisions of the Zacks Consensus Estimate for 2020 and 2021 earnings.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Coronavirus Vaccine Hopes Buoy Market: 4 Stocks to Tap the Rally
The Dow Jones Industrial Average (DJIA) has risen for four successive days, marking the longest winning streak in more than 30 days. This indicates positive investor sentiments, aided primarily by the promising progress in coronavirus vaccine study. Increased U.S. industrial production also added to the optimism.
Promising Vaccine Study
Moderna (MRNA - Free Report) has inched closer to a coronavirus vaccine, setting the stage for phase 3 trial by July-end, as suggested by a new study. The new details of the phase 1 study of the company’s experimental coronavirus vaccine showed that the vaccine induced desired neutralizing antibodies in 100% of the participants who were evaluated.
Notably, no serious side effects were reported by the participants through the study period, signifying that the vaccine was well tolerated and safe. Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, appreciated the study and added that the data from the phase 1 trial has established the fact that the candidate is well capable of inducing sufficient neutralizing antibodies.
It is widely expected that the results from the large study will come out by 2020-end.
Sign of Economic Recovery
Industrial production in the United States increased 5.4% in June following the improvement of 1.4% in May, according to the Federal Reserve statistical release. Thus, U.S. manufacturing has increased for two months in a row after declining 12.7% in April. Notably, the rise in industrial production was higher than the expectations of most economists.
Importantly, social-distancing measures were eased and people returned to work as factories in the United States reopened in May and June. This has helped industrial production recover from its record decline in April.
Stocks in the Spotlight
With the string of positive developments aiding the stock market rally, it will be wise for the investors to invest in growth stocks. Growth stocks usually grow at a rate higher than the market’s average. Hence, we have shortlisted four stocks that flaunt a Zacks Rank #1 (Strong Buy) and possess a Growth Score of A. You can see the complete list of today’s Zacks #1 Rank stocks here.
BJ’s Wholesale Club Holdings, Inc. (BJ - Free Report) : BJ’s Wholesale is an operator of membership warehouse clubs, primarily in the U.S. East Coast. Notably, this Westborough, MA-headquartered company’s expected EPS growth rate for the next five years is 13.5%, which compares favorably with the industry's 12.3%.
Asbury Automotive Group, Inc. (ABG - Free Report) is a leading automotive retailer in the domestic market. The stock is likely to see earnings growth of 2.9% and 22.7% in 2020 and 2021, respectively. The company, headquartered in Duluth, GA, has also beat the Zacks Consensus Estimate in three of the past four reported quarters.
DCP Midstream, LP has operating interests in midstream energy infrastructures spreading across the United States. The partnership has witnessed no revisions in the Zacks Consensus Estimate for 2020 bottom line in the past 30 days. For 2021, the partnership has seen upward revisions for the consensus estimate of earnings over the same period.
Based in Covington, LA, Pool Corporation (POOL - Free Report) is among the largest distributors of swimming pool supplies in the world. In the past 60 days, the company has seen upward revisions of the Zacks Consensus Estimate for 2020 and 2021 earnings.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>